FarsNewsAgency - خبرگزاري فارس
Turkish / Persian / Arabic / English 4  Safar  1430 /  Friday 30 Jan 2009 / 11 Bahman 1387 a
Tehran - 06:02 / GMT - 02:32

Mainpage


All Stories

Politics
Economy
Social
World
Culture
Foreign Policy
Nuclear
Sports
Science
Art
Defence
Photo


Search

Contact us

About us


News number: 8710121087

20:12 | 2009-01-01

Science

نسخه چاپي ارسال به دوستان

Iran's Angipars Treats Scleroderma

TEHRAN (FNA)- Iranian researches believe Angipars, the first herbal anti-diabetic medication, can effectively treat the scleroderma skin disorder.



Scleroderma is an autoimmune disease of the connective tissue characterized by the formation of scar tissue (fibrosis) in the skin and other organs, leading to severe disability.

The disease commonly affects the hands, resulting in severe disability in moving the extremities; rapidly progressing ulcers aggravate the situation making amputation inevitable.

"Angipars offers new hope for individuals suffering from the difficult-to-treat scleroderma", Head of the Iranian Rheumatism Research Center Farhad Gharib-Doost said, press tv reported.

Gharib-Doost added that Angipars has shown promising results in treating the wounds of scleroderma patients.

The medication not only improves the healing process of the wounds but also accelerates the regrowth of damaged tissue; it also helps smooth the skin and tackles discoloration, leading to an improved quality of life in patients.

Gharib-Doost concluded that Angipars has been much more effective in treating vascular lesions than diabetic foot ulcers.